semaglutide glp1 A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus | Diabetes Therapy Five Unexpected New Uses for
Description
With an eligible patient pool of nearly 10 crore Indians, capturing even a 2-3% conversion rate creates a growing category
Secondary parameters were fasting glucose and total lean mass
Better adherence: Taking one injection weekly is easier to remember and maintain than daily injections
doi: 10.1161/JAHA.122.028409
Telemedicine platforms have made this process more accessible, with many offering consultations, prescriptions, and pharmacy coordination
During the preparation of this manuscript, we used ChatGPT (OpenAI) to support reference formatting and language clarity
